Sirona Biochem Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SRBCF research report →
Price Chart
About the company
Sirona Biochem Corp. operates as a biotechnology company dedicated to uncovering and commercializing active ingredients for both cosmetic and pharmaceutical uses, with a commercial presence in Canada and France. Key initiatives include the development of a cosmetic skin brightener and a pharmaceutical solution for diabetes.
- CEO
- Howard J. Verrico
- IPO
- 2013
- Employees
- 10
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on SRBCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.63M
- P/E
- -0.72
- PEG
- 0.04
- P/S
- 67.05
- P/B
- -0.73
- EV/EBITDA
- -1.69
- Div Yield
- 0.00%
- Gross Margin
- -82.71%
- Op Margin
- -6917.60%
- Net Margin
- -7312.43%
- ROE
- 221.45%
- ROIC
- 1259.21%
Latest fiscal year · YoY change
- Revenue
- $34.78K-94.8%
- Gross Profit
- $-28,767-104.6%
- Op Income
- $-2,405,872
- Net Income
- $-2,543,190+28.5%
- EPS
- $-0.01+31.8%
- OCF Growth
- +19.3%
- FCF Growth
- +19.3%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- -0.07
- RSI (14)
- 52
- Avg Volume
- 15
No earnings-call transcripts are available for SRBCF yet.
- Free Float
- 76.5%
- Shares Outstanding
- 320.56M
- Float Shares
- 245.12M
Our SRBCF coverage
Recent articles, reports, and earnings notes.
No research on SRBCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SRBCF report →Sirona Biochem Update to Shareholders on Financial Status and Operations
globenewswire.com · Aug 1
Sirona Biochem Announces Debenture Financing
globenewswire.com · Apr 22
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
globenewswire.com · Apr 22
Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report
globenewswire.com · Jan 15
Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology
globenewswire.com · Nov 20
SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout
globenewswire.com · Sep 25
GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
globenewswire.com · Jun 18
SIRONA BIOCHEM Corporate Update April 2024
globenewswire.com · Apr 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.